An interventional study of V-NOTES Mesh-Free Sacrocolpopexy and Laparoscopic Mesh-Free Sacrocolpopexy in Pelvic Organ Prolapse, sponsored by Havva Betül Bacak. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-07-24.
Sponsored by Havva Betül Bacak · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 40 studies in Pelvic Organ Prolapse with a site in Turkey — 5 open to participants now, 6 under way, 1 of them phase 3. Pelvic Organ Prolapse · Turkey.
Among the 40 studies in Pelvic Organ Prolapse with a site in Turkey, this one is the 14th largest by planned enrollment of the 26 interventional ones that give a count, is one of 5 that started in 2025, is one of 25 with no phase, and was the 34th registered.
522 studies on the registry are indexed under Pelvic Organ Prolapse; 81 are open to participants now.
Browse Pelvic Organ Prolapse studies →5 of the 40 studies in Pelvic Organ Prolapse with a site in Turkey are open now. Recruiting first, the newest first:
Erkan Gol · Sites in Turkey
Ages 18+ · Women only
Gaziosmanpasa Research and Education Hospital · Sites in Turkey
Ages 35–65 · Women only
Gaziosmanpasa Research and Education Hospital · Sites in Turkey
Ages 18–75 · Women only
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization · Sites in Turkey
Ages 18–80 · Women only · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 53 Pelvic Organ Prolapse studies recruiting now, 31 (58%) set no upper age limit and 10 (19%) stop at 75 or younger; 2 take children under 18; 14 take healthy volunteers.
This study: 18 Years to 75 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
40 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 5 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 52 is below the median of 80 across 337 interventional studies indexed under Pelvic Organ Prolapse.
Median enrollment 55 across the 26 interventional studies, 86 across the 14 observational. Of the 28 that completed or were terminated, 1 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 40 has an industry lead sponsor. The 10 most frequent:
Havva Betül Bacak is the lead sponsor of 9 studies on the registry; 3 are open to participants now.
Havva Betül Bacak has 3 studies filed under Pelvic Organ Prolapse — fewer than ten, so there is no comparison to draw.
1 of the studies in Pelvic Organ Prolapse with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07440576Erkan GolEffect of Paracervical Block on Postoperative Pain After vNOTES Uterosacral Ligament Suspension | 2027-02 |
Add it to your calendar (.ics) → With an account.
Among the 40 studies in Pelvic Organ Prolapse with a site in Turkey, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to compare the surgical outcomes, safety profiles, and patient satisfaction between two minimally invasive techniques for pelvic organ prolapse repair: Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) mesh-free sacrocolpopexy and laparoscopic mesh-free sacrocolpopexy. By evaluating perioperative data, complication rates, anatomical and functional outcomes, this trial seeks to determine whether the V-NOTES approach provides comparable or superior results to the traditional laparoscopic technique, without the use of synthetic mesh.
Pelvic organ prolapse (POP) is a common condition among women, especially with increasing age and parity, often requiring surgical intervention. Sacrocolpopexy is considered the gold standard for apical prolapse repair due to its high anatomical success rate and long-term durability. Traditionally performed via open or laparoscopic approaches, sacrocolpopexy has evolved with minimally invasive techniques.
Recently, mesh-related complications have led to a growing interest in mesh-free alternatives. Simultaneously, natural orifice approaches such as Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) have gained popularity due to better cosmetic results, reduced postoperative pain, and faster recovery times.
This prospective, comparative study aims to evaluate and compare the clinical outcomes of mesh-free sacrocolpopexy performed via V-NOTES versus the laparoscopic approach. Parameters including operative time, intraoperative and postoperative complications, hospital stay, pain scores, anatomical success, and patient satisfaction will be analyzed. The goal is to assess whether V-NOTES can be a safe and effective alternative to laparoscopic mesh-free sacrocolpopexy in the surgical management of POP.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients undergoing mesh-free sacrocolpopexy via vaginal natural orifice transluminal endoscopic surgery (V-NOTES).
Procedure: V-NOTES Mesh-Free Sacrocolpopexy
Patients undergoing mesh-free sacrocolpopexy via conventional laparoscopy.
Procedure: Laparoscopic Mesh-Free Sacrocolpopexy
Mesh-free sacrocolpopexy performed via vaginal natural orifice transluminal endoscopic surgery (V-NOTES).
Mesh-free sacrocolpopexy performed via conventional laparoscopy.
Change in Pelvic Organ Prolapse Quantification (POP-Q) stage from baseline to 6 months
Anatomical success will be evaluated using the POP-Q system. A reduction of prolapse stage by at least one level or achieving stage 0-1 will be considered successful.
Time frame: Baseline and 6 months postoperative
Change in PISQ-12 Score
Sexual function will be evaluated with PISQ-12. An increase in score indicates improvement.
Time frame: Baseline and 6 months postoperative
Change in Pelvic Floor Distress Inventory-20 (PFDI-20) Score
Patient-reported symptoms related to pelvic floor distress will be evaluated using the PFDI-20. A decrease in score indicates improvement in symptoms.
Time frame: Baseline and 6 months postoperative
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2025 (actual). Primary completion is estimated for Jan 2026, 6 months after the start.
Of 162 non-industry interventional studies with no phase under Pelvic Organ Prolapse, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 43. This study's planned 6 months is below that.
Counting every sponsor, half of 179 studies reached it within 23 months; a quarter within 12 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Havva Betül Bacak